A longitudinal study of the effect of vitamin K2 on bone mineral density in postmenopausal women a comparative study with vitamin D3 and estrogen-progestin therapy

被引:57
作者
Iwamoto, I
Kosha, S
Noguchi, S
Murakami, M
Fujino, T
Douchi, T
Nagata, Y
机构
[1] Kagoshima Univ, Fac Med, Dept Obstet & Gynecol, Kagoshima 8908520, Japan
[2] Kagoshima Univ, Sch Allied Med Sci, Kagoshima 8908520, Japan
关键词
vitamin K-2; bone mineral density; treatment;
D O I
10.1016/S0378-5122(98)00114-5
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objectives: To investigate the effect of vitamin K-2 treatment for a year on spinal bone mineral density (BMD) in postmenopausal women, comparing with vitamin D-3 hormone replacement therapy and to determine the factors which affect the efficacy of vitamin K-2 therapy. Subjects and methods: Seventy-two postmenopausal women were randomized into four groups and treated with respective agents. Before the therapy, 6 and 12 months after the treatment, their lumbar spine BMD were measured by dual energy X-ray absorptiometry. The rates of change in BMD (Delta BMD) were calculated. Correlations of BMD with age, year since menopause and the initial BMD were determined. Results: Vitamin K-2 suppressed the decrease in spinal BMD as compared with no treatment group. BMD in women treated with vitamin K-2 was inversely correlated with their age (r = -0.54; P < 0.05). Conclusions: Vitamin K-2, therapy may be a useful method for preventing postmenopausal spinal bone mineral loss. In addition, the therapy should be started early in postmenopausal period. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:161 / 164
页数:4
相关论文
共 13 条
[1]   EFFECT OF VITAMIN-K-2 (MENATETRENONE) ON OSTEOCLAST-LIKE CELL-FORMATION IN MOUSE BONE-MARROW CULTURES [J].
AKIYAMA, Y ;
HARA, K ;
TAJIMA, T ;
MUROTA, S ;
MORITA, I .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 263 (1-2) :181-185
[2]   EFFECTS OF MENATETRENONE ON BONE LOSS INDUCED BY OVARIECTOMY IN RATS [J].
AKIYAMA, Y ;
HARA, K ;
OHKAWA, I ;
TAJIMA, T .
JAPANESE JOURNAL OF PHARMACOLOGY, 1993, 62 (02) :145-153
[3]   FRACTURE HEALING BY VITAMIN-K [J].
BOUCKAERT, JH ;
SAID, AH .
NATURE, 1960, 185 (4716) :849-849
[4]  
CHRISTIANSEN C, 1981, LANCET, V1, P459
[5]   MATERNAL AND FETAL SEQUELAE OF ANTICOAGULATION DURING PREGNANCY [J].
HALL, JG ;
PAULI, RM ;
WILSON, KM .
AMERICAN JOURNAL OF MEDICINE, 1980, 68 (01) :122-140
[6]   EFFECTS OF MENATETRENONE ON PREDNISOLONE-INDUCED BONE LOSS IN RATS [J].
HARA, K ;
AKIYAMA, Y ;
OHKAWA, I ;
TAJIMA, T .
BONE, 1993, 14 (06) :813-818
[7]  
HARA K, 1993, J BONE MINER RES, V8, P535
[8]   ELECTROCHEMICAL DETECTION OF DEPRESSED CIRCULATING LEVELS OF VITAMIN-K1 IN OSTEOPOROSIS [J].
HART, JP ;
SHEARER, MJ ;
KLENERMAN, L ;
CATTERALL, A ;
REEVE, J ;
SAMBROOK, PN ;
DODDS, RA ;
BITENSKY, L ;
CHAYEN, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 60 (06) :1268-1269
[9]  
HAUSCHKA PV, 1978, J BIOL CHEM, V253, P9063
[10]   VITAMIN-K(2) (MENATETRENONE) INHIBITS PROSTAGLANDIN SYNTHESIS IN CULTURED HUMAN OSTEOBLAST-LIKE PERIOSTEAL CELLS BY INHIBITING PROSTAGLANDIN H SYNTHASE ACTIVITY [J].
KOSHIHARA, Y ;
HOSHI, K ;
SHIRAKI, M .
BIOCHEMICAL PHARMACOLOGY, 1993, 46 (08) :1355-1362